gptkbp:instanceOf
|
gptkb:disease
autoimmune disease
|
gptkbp:affects
|
adolescents
adults
children
pancreas
|
gptkbp:alsoKnownAs
|
gptkb:juvenile_diabetes
|
gptkbp:associatedWith
|
autoantibodies
|
gptkbp:cannotBePreventedBy
|
lifestyle changes
|
gptkbp:cause
|
gptkb:hypoglycemia
hyperglycemia
|
gptkbp:causedBy
|
autoimmune destruction of beta cells
|
gptkbp:characterizedBy
|
insulin deficiency
|
gptkbp:complication
|
gptkb:cardiovascular_disease
gptkb:diabetic_ketoacidosis
gptkb:nephropathy
peripheral neuropathy
retinopathy
|
gptkbp:diagnosedBy
|
blood glucose test
HbA1c test
|
gptkbp:firstDescribed
|
19th century
|
https://www.w3.org/2000/01/rdf-schema#label
|
Type 1 Diabetes
|
gptkbp:ICD-10_code
|
E10
|
gptkbp:incidence
|
increasing worldwide
|
gptkbp:managedBy
|
gptkb:food
exercise
blood sugar monitoring
|
gptkbp:monitors
|
continuous glucose monitor
fingerstick blood test
|
gptkbp:notableContributor
|
gptkb:Frederick_Banting
gptkb:Charles_Best
|
gptkbp:onset
|
childhood
adolescence
adulthood
|
gptkbp:prevalence
|
less common than type 2 diabetes
|
gptkbp:relatedTo
|
gptkb:Type_2_Diabetes
gptkb:Latent_autoimmune_diabetes_in_adults
|
gptkbp:requires
|
lifelong management
|
gptkbp:riskFactor
|
family history
genetic predisposition
environmental factors
|
gptkbp:symptom
|
fatigue
frequent urination
increased thirst
unintended weight loss
|
gptkbp:treatment
|
gptkb:insulin
insulin therapy
multiple daily injections
|
gptkbp:bfsParent
|
gptkb:Fasting_Blood_Sugar
|
gptkbp:bfsLayer
|
6
|